These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8675553)

  • 1. Tibolone as an alternative to estrogen for the prevention of postmenopausal osteoporosis in selected postmenopausal women.
    Riggs BL
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2417-8. PubMed ID: 8675553
    [No Abstract]   [Full Text] [Related]  

  • 2. Tibolone and the promise of ideal hormone-replacement therapy.
    El-Hajj Fuleihan G
    N Engl J Med; 2008 Aug; 359(7):753-5. PubMed ID: 18703480
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone.
    Lippuner K; Haenggi W; Birkhaeuser MH; Casez JP; Jaeger P
    J Bone Miner Res; 1997 May; 12(5):806-12. PubMed ID: 9144347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].
    Reginster JY
    J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6):541-9. PubMed ID: 12407324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tibolone: a unique version of hormone replacement therapy.
    Swegle JM; Kelly MW
    Ann Pharmacother; 2004 May; 38(5):874-81. PubMed ID: 15026563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tibolone in older postmenopausal women.
    Chlebowski RT; Prentice R
    N Engl J Med; 2008 Nov; 359(20):2172-3; author reply 2173. PubMed ID: 19005202
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential effects of alternatives to hormone replacement therapy in postmenopausal healthy women.
    Bjarnason NH
    Dan Med Bull; 2005 May; 52(2):64-81. PubMed ID: 16009050
    [No Abstract]   [Full Text] [Related]  

  • 8. Spanish Menopause Society position statement: use of tibolone in postmenopausal women.
    Mendoza N; Abad P; Baró F; Cancelo MJ; Llaneza P; Manubens M; Quereda F; Sánchez-Borrego R
    Menopause; 2013 Jul; 20(7):754-60. PubMed ID: 23793166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tibolone--a new steroid for therapy of the climacteric syndrome and prevention of osteoporosis].
    Presl J
    Cesk Gynekol; 1991 May; 56(4):299-301. PubMed ID: 1913870
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of tibolone on the breast of postmenopausal women.
    Wang PH; Cheng MH; Chao HT; Chao KC
    Taiwan J Obstet Gynecol; 2007 Jun; 46(2):121-6. PubMed ID: 17638619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical trial with tibolone in postmenopausal replacement therapy].
    Zarate A; Hernandez M; Ochoa R; Santos A
    Ginecol Obstet Mex; 1996 Jan; 64():47-50. PubMed ID: 8948925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of tibolone on bone mineral density in postmenopausal women with osteopenia or osteoporosis--8 years follow-up.
    Prelevic GM; Markou A; Arnold A; Bartram C; Puzigaca Z; Ginsburg J
    Maturitas; 2004 Mar; 47(3):229-34. PubMed ID: 15036493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial effects of tibolone in elderly, osteoporotic women.
    Ettinger B; Kenemans P; Johnson SR; Mol-Arts M; Van Os S; Seifert W; Verweij PJ; Cummings SR
    Obstet Gynecol; 2008 Sep; 112(3):653-9. PubMed ID: 18757665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tibolone and its effects on bone: a review.
    Berning B; Bennink HJ; Fauser BC
    Climacteric; 2001 Jun; 4(2):120-36. PubMed ID: 11428176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of bone loss with tibolone in postmenopausal women: results of two randomized, double-blind, placebo-controlled, dose-finding studies.
    Gallagher JC; Baylink DJ; Freeman R; McClung M
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4717-26. PubMed ID: 11600531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone therapy in the WHI era.
    Burger HG
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):84-91. PubMed ID: 16638027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
    Ziaei S; Moghasemi M; Faghihzadeh S
    Climacteric; 2010 Apr; 13(2):147-56. PubMed ID: 19731119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tibolone for postmenopausal women: systematic review of randomized trials.
    Modelska K; Cummings S
    J Clin Endocrinol Metab; 2002 Jan; 87(1):16-23. PubMed ID: 11788614
    [No Abstract]   [Full Text] [Related]  

  • 19. Tibolone (Livial)--a new steroid for the menopause.
    Drug Ther Bull; 1991 Sep; 29(20):77-8. PubMed ID: 1935591
    [No Abstract]   [Full Text] [Related]  

  • 20. Updated clinical recommendations for the use of tibolone in Asian women.
    Huang KE; Baber R;
    Climacteric; 2010 Aug; 13(4):317-27. PubMed ID: 20443720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.